« Initiation of Phase I Part B | Main | Initiation of Phase I clinical trial »

Participation in Bill & Melinda Gates Foundation Grant

MinervaX announces that the company is a participant in a BMGF grant worth USD 0.5 million awarded to Professor Sharbir Madhi, South Africa for studies on correlates of protection focusing on naturally occurring antibodies directed at the company’s vaccine antigens. Co.applicatant of the grant is also Professor Bengt Johansson-Lindbom, Lund University, Sweden.